JP2025510490A5 - - Google Patents

Info

Publication number
JP2025510490A5
JP2025510490A5 JP2024547780A JP2024547780A JP2025510490A5 JP 2025510490 A5 JP2025510490 A5 JP 2025510490A5 JP 2024547780 A JP2024547780 A JP 2024547780A JP 2024547780 A JP2024547780 A JP 2024547780A JP 2025510490 A5 JP2025510490 A5 JP 2025510490A5
Authority
JP
Japan
Application number
JP2024547780A
Other languages
Japanese (ja)
Other versions
JP2025510490A (ja
JPWO2023194271A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/058605 external-priority patent/WO2023194271A1/en
Publication of JP2025510490A publication Critical patent/JP2025510490A/ja
Publication of JP2025510490A5 publication Critical patent/JP2025510490A5/ja
Publication of JPWO2023194271A5 publication Critical patent/JPWO2023194271A5/ja
Pending legal-status Critical Current

Links

JP2024547780A 2022-04-04 2023-04-03 抗c5抗体クロバリマブの使用によるギラン・バレー症候群の治療または予防のための投薬量および投与レジメン Pending JP2025510490A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22166586 2022-04-04
EP22166586.2 2022-04-04
PCT/EP2023/058605 WO2023194271A1 (en) 2022-04-04 2023-04-03 Dosage and administration regimen for the treatment or prevention of guillan-barré syndrome by the use of the anti-c5 antibody crovalimab

Publications (3)

Publication Number Publication Date
JP2025510490A JP2025510490A (ja) 2025-04-15
JP2025510490A5 true JP2025510490A5 (https=) 2026-04-03
JPWO2023194271A5 JPWO2023194271A5 (https=) 2026-04-03

Family

ID=81327980

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024547780A Pending JP2025510490A (ja) 2022-04-04 2023-04-03 抗c5抗体クロバリマブの使用によるギラン・バレー症候群の治療または予防のための投薬量および投与レジメン

Country Status (11)

Country Link
US (1) US20250236661A1 (https=)
EP (1) EP4504773A1 (https=)
JP (1) JP2025510490A (https=)
KR (1) KR20240168923A (https=)
CN (1) CN118556078A (https=)
AU (1) AU2023248634A1 (https=)
CA (1) CA3251879A1 (https=)
IL (1) IL313962A (https=)
MX (1) MX2024009673A (https=)
TW (1) TW202346339A (https=)
WO (1) WO2023194271A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107207607B (zh) 2014-12-19 2021-05-04 中外制药株式会社 抗-c5抗体及使用方法
US20230303670A1 (en) * 2020-06-24 2023-09-28 Alexion Pharmaceuticals, Inc. Subcutaneous (sc) administration of anti-c5 antibodies for treatment of complement-associated conditions

Similar Documents

Publication Publication Date Title
CL2025003693A1 (es) Barra colectora conductora rectangular tubular con núcleo macizo y disipación de calor interna
BR102022025291A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
JP2025510490A5 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR202022005961U2 (https=)
BY13170U (https=)
CN307047007S (https=)
BY23963C1 (https=)
CN307044348S (https=)
BY13176U (https=)
BY13175U (https=)
BY13174U (https=)
CN307044928S (https=)
BY13172U (https=)
BY13159U (https=)
CN307045310S (https=)